MedPath

Comparison of Ketorolac and Parecoxib for Postoperative Outcome in Total Knee Arthroplasty

Phase 3
Recruiting
Conditions
patient have knee pain with the diagnosis of osteoarthritis. The patient have been scheduled for unilateral total knee arthroplasty.
Total knee arthroplasty&#44
ketorolac&#44
parecoxib
Registration Number
TCTR20170619007
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

patient have knee pain with the diagnosis of osteoarthritis. And the patient have been scheduled for unilateral total knee arthroplasty.

Exclusion Criteria

1. pregnant
2. had previous knee surgery
3. History of knee infection
4. allergy to medicine used in the trials
5. history of deep vein thrombosis
6. heart disease
7. cerebrovascular disease
8. peptic ulcer
9. kidney disease
10. liver disease
11. Hemoglobin less than 30 mg/dl

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain score 6, 12,24, 48, 72, 96 hour postoperative Visual analoque scale,Degree of Knee flexion, Straight leg raising and extension lag 6, 12,24, 48, 72, 96 hour postoperative Goniometer,Morphine consumption 24, 48, 72, 96 hour postoperative amount of morphine use from PCA
Secondary Outcome Measures
NameTimeMethod
Perioperative blood loss preoperative and 24 hour postoperative Balance calculation method,Drainage blood loss 24, 48 hour postoperative Amount of blood discharge in drain,Renal function 6, 12,24, 48, 72, 96 hour postoperative Creatine clearance
© Copyright 2025. All Rights Reserved by MedPath